Results 301 to 310 of about 444,049 (319)
Some of the next articles are maybe not open access.

Vascular adhesion protein-1 (VAP-1) is overexpressed in psoriatic patients

Journal of the European Academy of Dermatology and Venereology, 2007
Adam Reich, Jacek C Szepietowski
exaly   +1 more source

Serum vascular adhesion protein-1 is increased in acute and chronic hyperglycemia

Clinica Chimica Acta, 2009
The relationship between serum vascular adhesion protein-1 (VAP-1) and plasma glucose in normal and drug-naïve type 2 diabetes subjects is unclear. We examined if serum VAP-1 changed acutely to oral glucose loading and analyzed the relationship between serum VAP-1, fasting plasma glucose (FPG), hemoglobin A1c, and type 2 diabetes.Adults without history
Hung-Yuan Li   +11 more
openaire   +3 more sources

Vascular Adhesion Protein‐1 as a Potential Therapeutic Target in Liver Disease

Annals of the New York Academy of Sciences, 2007
Abstract:  Vascular adhesion protein‐1 (VAP‐1) is a homodimeric, transmembrane sialoglycoprotein, and amine‐oxidase enzyme constitutively expressed by hepatic endothelial cells, and as a soluble protein in serum (sVAP‐1). VAP‐1 mediates leukocyte adhesion and migration in an enzyme activity‐dependent manner.
Patricia F, Lalor   +5 more
openaire   +2 more sources

Vascular adhesion protein-1: Role in human pathology and application as a biomarker

Critical Reviews in Clinical Laboratory Sciences, 2015
Vascular adhesion protein-1 (VAP-1) is a member of the copper-containing amine oxidase/semicarbazide-sensitive amine oxidase (AOC/SSAO) enzyme family. SSAO enzymes catalyze oxidative deamination of primary amines, which results in the production of the corresponding aldehyde, hydrogen peroxide and ammonium.
Roos, Pannecoeck   +6 more
openaire   +2 more sources

Targeting Vascular Adhesion Protein‐1 to Treat Autoimmune and Inflammatory Diseases

Annals of the New York Academy of Sciences, 2007
Abstract:  The development of new, safe, and effective anti‐inflammatory drugs represents a major challenge for the pharmaceutical industry, as well as a significant opportunity. The increasing prevalence of chronic inflammatory and autoimmune diseases associated with an aging population has led to an intense effort to discover new anti‐inflammatory ...
David J, Smith, Petri J, Vainio
openaire   +2 more sources

[Vascular adhesion protein-1 (VAP-1) in inflammatory process].

Przeglad lekarski, 2006
VAP-1 is an adhesion molecule expressed on the surface of endothelial cells. It plays an important role in the adhesion and migration of leukocytes to the sites of inflammation. The purpose of this article is to present current knowledge of structure, biological function of VAP-1 and its use in clinical practice.
Małgorzata, Pietruczuk   +4 more
openaire   +1 more source

Vascular Adhesion Protein-1 Inhibition Provides Antiinflammatory Protection after an Intracerebral Hemorrhagic Stroke in Mice

Journal of Cerebral Blood Flow and Metabolism, 2011
Anatol Manaenko   +2 more
exaly  

Structure of human semicarbazide-sensitive amine oxidase/vascular adhesion protein-1

Acta Crystallographica Section D: Biological Crystallography, 2005
Gerard J Kleywegt
exaly  

Home - About - Disclaimer - Privacy